---

---

tags : Approval   

save search

---

INVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In Thailand
Published: 2021-12-01 (Crawled : 14:00) - invobioscience.com
INVO | $1.555 104.6% 51.13% 5M |

Health Technology

| -74.67% | O: 6.67% H: 4.06% C: -4.06%
approval bioscience commercialization

---

TRACON Pharmaceuticals Reports Regulatory Approval of Envafolimab in China
Published: 2021-11-29 (Crawled : 13:30) - globenewswire.com
TCON | $2.13 -6.99% -7.51% 350K |

Health Technology

| -16.42% | O: -1.46% H: 4.07% C: -4.07%
approval china

---

TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol
Published: 2022-03-10 (Crawled : 14:00) - globenewswire.com
TCON | $2.13 -6.99% -7.51% 350K |

Health Technology

| -6.91% | O: 6.1% H: 0.0% C: 0.0%
fda als fda approval approval

---

TRACON Pharmaceuticals Announces Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab
Published: 2022-08-29 (Crawled : 12:20) - globenewswire.com
TCON | $2.13 -6.99% -7.51% 350K |

Health Technology

| 13.93% | O: 6.97% H: 0.93% C: -7.44%
yh001 treatment antibody approval

---

Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
Published: 2024-01-23 (Crawled : 15:30) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.9M |

Health Technology

| 38.26% | O: 2.11% H: 1.03% C: -4.13%
vca-894 fda drug candidate approval treatment pharmaceuticals

---

Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis
Published: 2024-01-31 (Crawled : 14:30) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.9M |

Health Technology

| 43.56% | O: 1.37% H: 1.35% C: -2.7%
vtr-297 fda drug candidate approval treatment pharmaceuticals antifungal

---

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
Published: 2024-04-02 (Crawled : 23:00) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.9M |

Health Technology

| 27.18% | O: -2.43% H: 0.0% C: -2.74%
fanapt fda approval treatment

---

180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDA
Published: 2023-08-03 (Crawled : 12:00) - globenewswire.com
ATNF | $1.91 0.0% 91K |

| 62.64% | O: -3.3% H: 4.53% C: 1.02%
fda disease life approval update sciences meeting

---

Red Cat Receives DoD “Blue UAS” Approval for New Teal 2 sUAS to be Added to Cleared List
Published: 2023-06-21 (Crawled : 12:00) - globenewswire.com
RCAT | News | $1.055 -25.7% -34.6% 3.8M |

Information

| 13.6% | O: -8.8% H: 7.02% C: 1.75%
cleared approval

---

Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-13 (Crawled : 18:40) - fda.gov
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -31.59% | O: 0.03% H: 0.56% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 311.31% | O: 0.03% H: 1.03% C: 0.22%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -24.1% | O: 0.27% H: 0.33% C: 0.09%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 51.47% | O: -1.85% H: 0.42% C: -0.3%
YMAB | $14.97 -0.93% -0.94% 410K |

Health Technology

| -40.93% | O: 0.55% H: 5.75% C: 4.16%
VSTM | $10.19 -6.0% -6.38% 67K |

Health Technology

| 301.48% | O: -1.85% H: 2.64% C: 1.13%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -8.07% | O: 0.56% H: 0.18% C: -0.4%
RIGL | $1.06 -4.51% -4.72% 1.2M |

Health Technology

| -69.25% | O: -1.66% H: 9.58% C: 5.07%
REGN | $893.66 -0.84% -0.84% 450K |

Health Technology

| 88.91% | O: 0.2% H: 1.83% C: 0.66%
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -86.34% | O: 0.89% H: 5.1% C: 0.1%
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| -34.63% | O: 0.0% H: 3.18% C: 1.93%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -70.66% | O: 0.87% H: 0.47% C: -2.11%
EXEL | $22.47 -1.75% -1.78% 2.6M |

Health Technology

| -1.69% | O: -0.38% H: 4.2% C: 3.09%
EPZM | $1.47 -1.34% 0.0% |

Health Technology

| -82.04% | O: 0.18% H: 3.17% C: 0.24%
CLVS | $0.0812 -3.94% |

Health Technology

| -98.6% | O: 0.0% H: 4.56% C: 1.79%
BPMC | News | $88.9 0.59% 0.58% 730K |

Health Technology

| -7.51% | O: 0.37% H: 6.32% C: 3.68%
BGNE | $131.94 0.06% 0.06% 130K |

Health Technology

| -55.36% | O: 0.24% H: 2.16% C: -0.12%
AVEO | $15.0 0.0% 0 |

Health Technology

| 132.12% | O: 0.15% H: 2.63% C: -0.15%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 6.8% | O: 0.01% H: 0.61% C: -0.14%
ALNY | News | $145.045 -0.19% -0.19% 400K |

Health Technology

| 7.7% | O: 0.86% H: 2.16% C: 0.66%
AGIO | News | $29.43 1.38% 1.36% 550K |

Health Technology

| -44.68% | O: 0.73% H: 4.5% C: 1.75%
cancer approval

---

Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-22 (Crawled : 17:37) - fda.gov
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -35.69% | O: -0.13% H: 0.05% C: -2.13%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 293.18% | O: -0.5% H: 0.67% C: -1.55%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -27.23% | O: -0.26% H: 0.62% C: 0.26%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 47.95% | O: -0.14% H: 0.4% C: -0.54%
YMAB | $14.97 -0.93% -0.94% 410K |

Health Technology

| -43.41% | O: 0.37% H: 4.78% C: 0.9%
VSTM | $10.19 -6.0% -6.38% 67K |

Health Technology

| 284.4% | O: 0.35% H: 4.42% C: -0.35%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -12.1% | O: -0.93% H: 0.27% C: 0.17%
RIGL | $1.06 -4.51% -4.72% 1.2M |

Health Technology

| -69.92% | O: -0.27% H: 2.99% C: -0.54%
REGN | $893.66 -0.84% -0.84% 450K |

Health Technology

| 77.93% | O: -0.21% H: 0.0% C: -2.96%
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -85.61% | O: 0.42% H: 2.7% C: -0.1%
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| -37.77% | O: -0.26% H: 0.0% C: -0.38%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -70.67% | O: -0.32% H: 2.34% C: 1.59%
EXEL | $22.47 -1.75% -1.78% 2.6M |

Health Technology

| -6.67% | O: -0.61% H: 1.63% C: 0.57%
EPZM | $1.47 -1.34% 0.0% |

Health Technology

| -81.32% | O: 0.51% H: 1.39% C: -0.38%
CLVS | $0.0812 -3.94% |

Health Technology

| -98.57% | O: 0.63% H: 4.67% C: 0.86%
BPMC | News | $88.9 0.59% 0.58% 730K |

Health Technology

| -9.28% | O: 0.27% H: 1.3% C: -0.8%
BGNE | $131.94 0.06% 0.06% 130K |

Health Technology

| -55.61% | O: 0.0% H: 3.94% C: 3.0%
AVEO | $15.0 0.0% 0 |

Health Technology

| 124.81% | O: -0.15% H: 3.9% C: 1.2%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 3.15% | O: -0.48% H: 0.36% C: -0.97%
ALNY | News | $145.045 -0.19% -0.19% 400K |

Health Technology

| 6.68% | O: -0.79% H: 2.9% C: 0.97%
AGIO | News | $29.43 1.38% 1.36% 550K |

Health Technology

| -47.74% | O: 0.38% H: 1.41% C: -0.23%
cancer approval

---

Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-23 (Crawled : 18:42) - fda.gov
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| Email alert Add to watchlist
RIGL | $1.06 -4.51% -4.72% 1.2M |

Health Technology

| Email alert Add to watchlist
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| Email alert Add to watchlist
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| Email alert Add to watchlist
BGNE | $131.94 0.06% 0.06% 130K |

Health Technology

| Email alert Add to watchlist
CLVS | $0.0812 -3.94% |

Health Technology

| Email alert Add to watchlist
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| Email alert Add to watchlist
ALNY | News | $145.045 -0.19% -0.19% 400K |

Health Technology

| Email alert Add to watchlist
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| Email alert Add to watchlist
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| Email alert Add to watchlist
AGIO | News | $29.43 1.38% 1.36% 550K |

Health Technology

| Email alert Add to watchlist
VSTM | $10.19 -6.0% -6.38% 67K |

Health Technology

| Email alert Add to watchlist
EPZM | $1.47 -1.34% 0.0% |

Health Technology

| Email alert Add to watchlist
REGN | $893.66 -0.84% -0.84% 450K |

Health Technology

| Email alert Add to watchlist
AVEO | $15.0 0.0% 0 |

Health Technology

| Email alert Add to watchlist
YMAB | $14.97 -0.93% -0.94% 410K |

Health Technology

| Email alert Add to watchlist
BPMC | News | $88.9 0.59% 0.58% 730K |

Health Technology

| Email alert Add to watchlist
EXEL | $22.47 -1.75% -1.78% 2.6M |

Health Technology

| Email alert Add to watchlist
ADCT | $4.76 -4.03% 0.0% 280K |

Health Technology

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| Email alert Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| Email alert Add to watchlist
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| Email alert Add to watchlist
cancer approval

---

Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-14 (Crawled : 20:59) - fda.gov
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -31.61% | O: 0.24% H: 1.29% C: 0.91%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 310.26% | O: 0.43% H: 2.14% C: 1.16%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -24.37% | O: 0.3% H: 1.14% C: 0.69%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 54.79% | O: 0.08% H: 0.91% C: 0.85%
YMAB | $14.97 -0.93% -0.94% 410K |

Health Technology

| -43.6% | O: 0.22% H: 3.09% C: 1.68%
VSTM | $10.19 -6.0% -6.38% 67K |

Health Technology

| 304.48% | O: 1.87% H: 1.46% C: -1.47%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -8.22% | O: 0.76% H: 0.61% C: 0.14%
RIGL | $1.06 -4.51% -4.72% 1.2M |

Health Technology

| -70.24% | O: 2.41% H: 3.14% C: -1.05%
REGN | $893.66 -0.84% -0.84% 450K |

Health Technology

| 87.3% | O: 1.31% H: 2.43% C: 1.48%
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -86.47% | O: 0.39% H: 1.37% C: -5.37%
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| -35.87% | O: 0.8% H: 1.56% C: 0.4%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -70.28% | O: 1.43% H: 0.98% C: -0.45%
EXEL | $22.47 -1.75% -1.78% 2.6M |

Health Technology

| -4.26% | O: 1.0% H: 2.47% C: -1.4%
EPZM | $1.47 -1.34% 0.0% |

Health Technology

| -82.12% | O: 0.12% H: 2.67% C: 0.0%
CLVS | $0.0812 -3.94% |

Health Technology

| -98.62% | O: 0.0% H: 2.4% C: -2.4%
BPMC | News | $88.9 0.59% 0.58% 730K |

Health Technology

| -11.12% | O: -0.15% H: 1.63% C: -0.79%
BGNE | $131.94 0.06% 0.06% 130K |

Health Technology

| -55.41% | O: 0.0% H: 2.71% C: 2.38%
AVEO | $15.0 0.0% 0 |

Health Technology

| 132.12% | O: -0.15% H: 1.24% C: -2.33%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 6.94% | O: 0.59% H: 2.35% C: 1.6%
ALNY | News | $145.045 -0.19% -0.19% 400K |

Health Technology

| 6.08% | O: 1.05% H: 2.11% C: -0.53%
AGIO | News | $29.43 1.38% 1.36% 550K |

Health Technology

| -46.03% | O: 1.2% H: 3.28% C: 1.93%
cancer approval

---

Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-16 (Crawled : 18:04) - fda.gov
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -32.39% | O: 0.72% H: 2.19% C: 1.85%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 303.81% | O: 0.79% H: 1.56% C: 1.0%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -25.11% | O: 0.76% H: 1.09% C: 0.82%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 53.36% | O: 0.56% H: 0.99% C: 0.39%
YMAB | $14.97 -0.93% -0.94% 410K |

Health Technology

| -44.65% | O: 1.5% H: 0.22% C: -5.38%
VSTM | $10.19 -6.0% -6.38% 67K |

Health Technology

| 302.97% | O: 1.12% H: 0.0% C: -1.47%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -9.04% | O: 0.59% H: 0.96% C: 0.61%
RIGL | $1.06 -4.51% -4.72% 1.2M |

Health Technology

| -70.63% | O: 0.26% H: 0.0% C: -5.54%
REGN | $893.66 -0.84% -0.84% 450K |

Health Technology

| 82.19% | O: 0.41% H: 2.06% C: 1.2%
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -85.76% | O: -0.26% H: 2.95% C: 0.47%
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| -36.63% | O: 0.5% H: 0.3% C: -1.12%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -70.57% | O: -0.02% H: 0.12% C: -0.72%
EXEL | $22.47 -1.75% -1.78% 2.6M |

Health Technology

| -3.86% | O: -0.17% H: 0.84% C: -1.34%
EPZM | $1.47 -1.34% 0.0% |

Health Technology

| -82.14% | O: 0.97% H: 0.24% C: -2.59%
CLVS | $0.0812 -3.94% |

Health Technology

| -98.59% | O: -0.66% H: 1.16% C: -1.32%
BPMC | News | $88.9 0.59% 0.58% 730K |

Health Technology

| -10.28% | O: 1.16% H: 0.0% C: -1.92%
BGNE | $131.94 0.06% 0.06% 130K |

Health Technology

| -56.45% | O: -0.07% H: 0.18% C: -0.67%
AVEO | $15.0 0.0% 0 |

Health Technology

| 138.02% | O: -0.95% H: 0.16% C: -0.48%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 4.63% | O: 0.51% H: 0.93% C: -0.28%
ALNY | News | $145.045 -0.19% -0.19% 400K |

Health Technology

| 5.54% | O: 0.41% H: 0.34% C: -0.51%
AGIO | News | $29.43 1.38% 1.36% 550K |

Health Technology

| -47.67% | O: -0.45% H: 2.17% C: -0.18%
cancer approval

---

Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-07 (Crawled : 13:50) - fda.gov
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -29.49% | O: -0.06% H: 0.58% C: -0.33%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 310.71% | O: 0.05% H: 0.15% C: -0.32%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -22.14% | O: 0.05% H: 0.85% C: 0.08%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 55.56% | O: 0.14% H: 0.57% C: -0.3%
YMAB | $14.97 -0.93% -0.94% 410K |

Health Technology

| -48.88% | O: -1.89% H: 2.21% C: -2.28%
VSTM | $10.19 -6.0% -6.38% 67K |

Health Technology

| 283.04% | O: -1.77% H: 5.04% C: -0.36%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -7.39% | O: 0.74% H: 0.22% C: -0.38%
RIGL | $1.06 -4.51% -4.72% 1.2M |

Health Technology

| -66.77% | O: 0.75% H: 1.63% C: -3.42%
REGN | $893.66 -0.84% -0.84% 450K |

Health Technology

| 88.27% | O: 0.07% H: 1.66% C: 0.58%
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -86.82% | O: 0.0% H: 1.86% C: -2.2%
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| -36.62% | O: 0.4% H: 0.0% C: -2.55%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -71.49% | O: -0.65% H: 0.6% C: -2.81%
EXEL | $22.47 -1.75% -1.78% 2.6M |

Health Technology

| -1.31% | O: 0.47% H: 1.45% C: -0.09%
EPZM | $1.47 -1.34% 0.0% |

Health Technology

| -83.01% | O: 0.58% H: 1.38% C: -2.99%
CLVS | $0.0812 -3.94% |

Health Technology

| -98.75% | O: -0.72% H: 1.61% C: -3.94%
BPMC | News | $88.9 0.59% 0.58% 730K |

Health Technology

| -11.27% | O: -0.83% H: 0.33% C: -3.34%
BGNE | $131.94 0.06% 0.06% 130K |

Health Technology

| -59.29% | O: -0.53% H: 0.15% C: -1.82%
AVEO | $15.0 0.0% 0 |

Health Technology

| 111.79% | O: 0.0% H: 0.71% C: -3.81%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 7.16% | O: -0.37% H: 0.83% C: -0.02%
ALNY | News | $145.045 -0.19% -0.19% 400K |

Health Technology

| 3.32% | O: -0.46% H: 1.19% C: -0.49%
AGIO | News | $29.43 1.38% 1.36% 550K |

Health Technology

| -46.68% | O: -1.13% H: 0.99% C: -1.05%
cancer approval

---

Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Published: 2021-04-06 (Crawled : 01:00) - prnewswire.com
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -87.58% | O: 0.27% H: 0.27% C: -6.01%
solid tumors approval application

---

Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-05 (Crawled : 18:31) - fda.gov
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -36.4% | O: -3.73% H: 1.95% C: 1.85%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 289.38% | O: -0.65% H: 1.33% C: 1.22%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -25.39% | O: -0.12% H: 0.19% C: -0.22%
ADCT | $4.76 -4.03% 0.0% 280K |

Health Technology

| -79.82% | O: 3.45% H: 1.01% C: -0.66%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 41.58% | O: -0.67% H: 1.03% C: 0.94%
YMAB | $14.97 -0.93% -0.94% 410K |

Health Technology

| -46.61% | O: -0.85% H: 2.64% C: 2.1%
VSTM | $10.19 -6.0% -6.38% 67K |

Health Technology

| 266.22% | O: -2.03% H: 0.82% C: -1.72%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -8.84% | O: 0.55% H: 0.51% C: 0.29%
RIGL | $1.06 -4.51% -4.72% 1.2M |

Health Technology

| -68.01% | O: 0.0% H: 0.0% C: -6.05%
REGN | $893.66 -0.84% -0.84% 450K |

Health Technology

| 86.81% | O: 0.14% H: 4.11% C: 3.22%
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -82.98% | O: 0.37% H: 1.11% C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M |

Health Technology

| -35.14% | O: -0.09% H: 1.99% C: 1.35%
ILMN | $116.64 -1.4% -1.41% 1.8M |

Health Technology

| -68.74% | O: -0.64% H: 0.34% C: 0.31%
EXEL | $22.47 -1.75% -1.78% 2.6M |

Health Technology

| -3.94% | O: -0.88% H: 0.34% C: -2.27%
EPZM | $1.47 -1.34% 0.0% |

Health Technology

| -80.45% | O: -0.27% H: 0.0% C: -9.2%
CLVS | $0.0812 -3.94% |

Health Technology

| -98.53% | O: -0.34% H: 0.86% C: -2.91%
BPMC | News | $88.9 0.59% 0.58% 730K |

Health Technology

| -5.34% | O: -0.26% H: 2.88% C: 2.72%
BGNE | $131.94 0.06% 0.06% 130K |

Health Technology

| -56.11% | O: 0.14% H: 3.67% C: 2.67%
AVEO | $15.0 0.0% 0 |

Health Technology

| 121.49% | O: -0.3% H: 0.15% C: -1.78%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 7.05% | O: -0.03% H: 0.88% C: 0.81%
ALNY | News | $145.045 -0.19% -0.19% 400K |

Health Technology

| 10.59% | O: -0.51% H: 1.52% C: 0.08%
AGIO | News | $29.43 1.38% 1.36% 550K |

Health Technology

| -45.94% | O: -0.45% H: 4.45% C: 3.9%
cancer approval

---

Karyopharm Announces FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
Published: 2020-12-18 (Crawled : 17:11) - prnewswire.com
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -90.92% | O: 0.13% H: 18.27% C: 8.21%
approval fda fda approval therapy treatment

---

Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
Published: 2020-12-21 (Crawled : 00:12) - prnewswire.com
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -91.62% | O: 2.67% H: 1.3% C: -3.25%
fda approval fda approval therapy

---

Karyopharm Announces XPOVIO® (selinexor) Receives Regulatory Approval in Israel for the Treatment of Patients with Multiple Myeloma and Diffuse Large B-Cell Lymphoma
Published: 2021-02-04 (Crawled : 13:00) - biospace.com/
KPTI | $1.265 -8.33% -9.09% 1.3M |

Health Technology

| -90.65% | O: 1.63% H: 1.0% C: -2.67%
israel treatment approval t-cell

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---